Sporanox I.V.: Reviews: Testimonials, Uses and Side Effects

Medication indications

Sporanox I.V. 10 mg/ml concentrate and solvent for solution for infusion

Sporanox IV is indicated for the treatment of histoplasmosis.

Sporanox IV is indicated in the following systemic fungal conditions when first-line systemic anti-fungal therapy is inappropriate or has proved ineffective. (This may be due to underlying pathology, insensitivity of the pathogen or drug toxicity).

Treatment of aspergillosis, candidosis and cryptococcosis (including cryptococcal meningitis): in immunocompromised patients with cryptococcosis and in all patients with cryptococcosis of the central nervous system.

Consideration should be given to national and/or local guidance regarding the appropriate use of antifungal agents.

Route of administration: Injectable
Molecule: itraconazole

Patients' opinions on Sporanox I.V.

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.